ANBIO BIOTECHNOLOGY LTD
NNNN · NASDAQ
Updated at 2026-10-13 14:43:15
- Today's High
- $4.44
- Today’s Low
- $4.27
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $4.61
- Previous Close
- $4.41
- Volume
- 24.87K
- Market Cap
- $634.56M
- P/E Ratio
- 62.20X
- EPS
- $0.23
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- MEDICAL INSTRUMENTS & SUPPLIES
- Headquarters
- FRIEDRICH-EBERT-ANLAGE 35-37, FRANKFURT AM MAIN, GERMANY, 60327
- Country
- DE
- Listing Date
- 2025-02-19
- Fiscal Year End
- December
- Shares Outstanding
- 43.89M
- CIK
- 0001982708
- Website
- anbiobiotechnology.com
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally. The company is headquartered in Frankfurt am Main, Germany.
Financial Metrics
Revenue
2026-03-31
$4.73M
2025-09-30
$2.03M
2025-06-30
$5M
2024-12-31
$2.52M
Operating Expenses
2026-03-31
$1.06M
2025-09-30
$454.99K
2025-06-30
$945.2K
2024-12-31
$3.87M
Net Income
2026-03-31
$3.03M
2025-09-30
$1.3M
2025-06-30
$4.14M
2024-12-31
-$1.32M
Net Profit Margin
2026-03-31
64.14%
2025-09-30
64.14%
2025-06-30
82.83%
2024-12-31
-52.39%
Earnings Per Share
2026-03-31
--
2025-09-30
$0.09
2025-06-30
--
2024-12-31
--
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-03-31
$2.79M
2025-09-30
--
2025-06-30
$3.67M
2024-12-31
-$1.32M
Effective Tax Rate
2026-03-31
--
2025-09-30
--
2025-06-30
--
2024-12-31
--
| Item | 2026-03-31 | 2025-09-30 | 2025-06-30 | 2024-12-31 |
|---|---|---|---|---|
| Revenue | $4.73M | $2.03M | $5M | $2.52M |
| Operating Expenses | $1.06M | $454.99K | $945.2K | $3.87M |
| Net Income | $3.03M | $1.3M | $4.14M | -$1.32M |
| Net Profit Margin | 64.14% | 64.14% | 82.83% | -52.39% |
| Earnings Per Share | -- | $0.09 | -- | -- |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | $2.79M | -- | $3.67M | -$1.32M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.